High Dose Preoperative Cholecalciferol Supplementation and Perioperative Vitamin D Status
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
A growing body of evidence suggests that robust postoperative immune function is associated
with a lower risk of surgical site infections (SSIs). At the same time, vitamin D is
increasingly recognized as a key regulator of the innate and adaptive immune systems. The
investigators elected to conduct the current study in patients who will undergo colorectal
surgery since these patients are historically at higher risk of developing SSIs and therefore
would be ideal for future investigations.
Phase:
Phase 3
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Bio-Tech Pharmacal, Inc.
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins